FDA Recalls Blood Pressure Medication Due to Dissolution Issues

AI-generated NewsSnap summary based on source reporting.
Published: 2026-06-26
Category: health
Source: North American Community Hub (NCHStats)
Original source

The U.S. Food and Drug Administration has initiated a Class II nationwide recall for over 11,000 bottles of Chlorthalidone Tablets. This blood pressure medication is being recalled because some tablets failed dissolution testing. This issue could prevent the drug from dissolving properly in the body, potentially reducing its intended effectiveness.

Want more?

Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.

Open NewsSnap.ai